Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies

Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 35, Issue 14, 27 March 2017, Pages 1764-1769

Janie Parrino, Shelly A. McNeil, Steven J. Lawrence, Eva Kimby, Marco F. Pagnoni, Jon E. Stek, Yanli Zhao, Ivan S.F. Chan, Susan S. Kaplan,